CA2867507A1 - Preventing or treating periodontal disease - Google Patents
Preventing or treating periodontal disease Download PDFInfo
- Publication number
- CA2867507A1 CA2867507A1 CA2867507A CA2867507A CA2867507A1 CA 2867507 A1 CA2867507 A1 CA 2867507A1 CA 2867507 A CA2867507 A CA 2867507A CA 2867507 A CA2867507 A CA 2867507A CA 2867507 A1 CA2867507 A1 CA 2867507A1
- Authority
- CA
- Canada
- Prior art keywords
- applicator
- oral cavity
- cavity surface
- antimicrobial composition
- antimicrobial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000028169 periodontal disease Diseases 0.000 title claims abstract description 33
- 239000000203 mixture Substances 0.000 claims abstract description 165
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 113
- 210000000214 mouth Anatomy 0.000 claims abstract description 100
- 238000000034 method Methods 0.000 claims abstract description 73
- 239000004599 antimicrobial Substances 0.000 claims abstract description 30
- 238000006073 displacement reaction Methods 0.000 claims abstract description 20
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 28
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 28
- 150000002978 peroxides Chemical class 0.000 claims description 18
- 239000011148 porous material Substances 0.000 claims description 15
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical group OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 claims description 15
- 239000003242 anti bacterial agent Substances 0.000 claims description 13
- 229940088710 antibiotic agent Drugs 0.000 claims description 12
- 239000002245 particle Substances 0.000 claims description 12
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 claims description 8
- FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 claims description 8
- 239000004098 Tetracycline Substances 0.000 claims description 8
- 229960003022 amoxicillin Drugs 0.000 claims description 8
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 claims description 8
- 229960004099 azithromycin Drugs 0.000 claims description 8
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 claims description 8
- 239000003599 detergent Substances 0.000 claims description 8
- 229960003722 doxycycline Drugs 0.000 claims description 8
- 229960004023 minocycline Drugs 0.000 claims description 8
- ZVVSSOQAYNYNPP-UHFFFAOYSA-N olaflur Chemical compound F.F.CCCCCCCCCCCCCCCCCCN(CCO)CCCN(CCO)CCO ZVVSSOQAYNYNPP-UHFFFAOYSA-N 0.000 claims description 8
- 229960001245 olaflur Drugs 0.000 claims description 8
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 claims description 8
- 229960002180 tetracycline Drugs 0.000 claims description 8
- 229930101283 tetracycline Natural products 0.000 claims description 8
- 235000019364 tetracycline Nutrition 0.000 claims description 8
- 150000003522 tetracyclines Chemical class 0.000 claims description 8
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 7
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 7
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 7
- 239000003443 antiviral agent Substances 0.000 claims description 7
- 229960004830 cetylpyridinium Drugs 0.000 claims description 7
- NEUSVAOJNUQRTM-UHFFFAOYSA-N cetylpyridinium Chemical compound CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NEUSVAOJNUQRTM-UHFFFAOYSA-N 0.000 claims description 7
- 229960003260 chlorhexidine Drugs 0.000 claims description 7
- 235000003599 food sweetener Nutrition 0.000 claims description 7
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 claims description 7
- 229960002799 stannous fluoride Drugs 0.000 claims description 7
- 239000003765 sweetening agent Substances 0.000 claims description 7
- 229960003500 triclosan Drugs 0.000 claims description 7
- 208000005888 Periodontal Pocket Diseases 0.000 claims description 6
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 6
- 230000003442 weekly effect Effects 0.000 claims description 4
- 201000001245 periodontitis Diseases 0.000 abstract description 9
- 208000007565 gingivitis Diseases 0.000 abstract description 7
- 238000005282 brightening Methods 0.000 description 34
- -1 for example Substances 0.000 description 12
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 10
- 239000000499 gel Substances 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 210000003298 dental enamel Anatomy 0.000 description 9
- 239000012190 activator Substances 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000001506 calcium phosphate Substances 0.000 description 6
- 229910000389 calcium phosphate Inorganic materials 0.000 description 6
- 235000011010 calcium phosphates Nutrition 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 5
- 239000003381 stabilizer Substances 0.000 description 5
- 239000004677 Nylon Substances 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 229920001778 nylon Polymers 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000003472 neutralizing effect Effects 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 description 2
- RAEOEMDZDMCHJA-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-[2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]ethyl]amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CCN(CC(O)=O)CC(O)=O)CC(O)=O RAEOEMDZDMCHJA-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 240000001238 Gaultheria procumbens Species 0.000 description 2
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 2
- 244000024873 Mentha crispa Species 0.000 description 2
- 235000014749 Mentha crispa Nutrition 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 238000005299 abrasion Methods 0.000 description 2
- RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 229940078916 carbamide peroxide Drugs 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 2
- QGSCPWWHMSCFOV-RRABGKBLSA-N dectaflur Chemical compound [F-].CCCCCCCC\C=C\CCCCCCCC[NH3+] QGSCPWWHMSCFOV-RRABGKBLSA-N 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 229960003330 pentetic acid Drugs 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- RXZBMPWDPOLZGW-XMRMVWPWSA-N (E)-roxithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=N/OCOCCOC)/[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 RXZBMPWDPOLZGW-XMRMVWPWSA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 229940035437 1,3-propanediol Drugs 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- VILCJCGEZXAXTO-UHFFFAOYSA-N 2,2,2-tetramine Chemical compound NCCNCCNCCN VILCJCGEZXAXTO-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- ACTOXUHEUCPTEW-BWHGAVFKSA-N 2-[(4r,5s,6s,7r,9r,10r,11e,13e,16r)-6-[(2s,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2s,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-o Chemical compound O([C@H]1/C=C/C=C/C[C@@H](C)OC(=O)C[C@@H](O)[C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)[C@@H]1CC[C@H](N(C)C)[C@@H](C)O1 ACTOXUHEUCPTEW-BWHGAVFKSA-N 0.000 description 1
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical group [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- FCKYPQBAHLOOJQ-UHFFFAOYSA-N Cyclohexane-1,2-diaminetetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)C1CCCCC1N(CC(O)=O)CC(O)=O FCKYPQBAHLOOJQ-UHFFFAOYSA-N 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229930182827 D-tryptophan Natural products 0.000 description 1
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 108010092160 Dactinomycin Proteins 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- XDXDZDZNSLXDNA-TZNDIEGXSA-N Idarubicin Chemical compound C1[C@H](N)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2C[C@@](O)(C(C)=O)C1 XDXDZDZNSLXDNA-TZNDIEGXSA-N 0.000 description 1
- XDXDZDZNSLXDNA-UHFFFAOYSA-N Idarubicin Natural products C1C(N)C(O)C(C)OC1OC1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2CC(O)(C(C)=O)C1 XDXDZDZNSLXDNA-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 229930192392 Mitomycin Natural products 0.000 description 1
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
- 244000227633 Ocotea pretiosa Species 0.000 description 1
- 235000004263 Ocotea pretiosa Nutrition 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000004187 Spiramycin Substances 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical class [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 1
- NSOXQYCFHDMMGV-UHFFFAOYSA-N Tetrakis(2-hydroxypropyl)ethylenediamine Chemical compound CC(O)CN(CC(C)O)CCN(CC(C)O)CC(C)O NSOXQYCFHDMMGV-UHFFFAOYSA-N 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- 208000008312 Tooth Loss Diseases 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 239000004182 Tylosin Substances 0.000 description 1
- 229930194936 Tylosin Natural products 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- PENDGIOBPJLVBT-HMMOOPTJSA-N abt-773 Chemical compound O([C@@H]1[C@@H](C)C(=O)[C@@H](C)C(=O)O[C@@H]([C@]2(OC(=O)N[C@@H]2[C@@H](C)C(=O)[C@H](C)C[C@]1(C)OC\C=C\C=1C=C2C=CC=CC2=NC=1)C)CC)[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O PENDGIOBPJLVBT-HMMOOPTJSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000003513 alkali Chemical class 0.000 description 1
- 229910052783 alkali metal Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Chemical class 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 229940045799 anthracyclines and related substance Drugs 0.000 description 1
- ZDQSOHOQTUFQEM-PKUCKEGBSA-N ascomycin Chemical compound C/C([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@@H](OC)C[C@@H](C)C\C(C)=C/[C@H](C(C[C@H](O)[C@H]1C)=O)CC)=C\[C@@H]1CC[C@@H](O)[C@H](OC)C1 ZDQSOHOQTUFQEM-PKUCKEGBSA-N 0.000 description 1
- ZDQSOHOQTUFQEM-XCXYXIJFSA-N ascomycin Natural products CC[C@H]1C=C(C)C[C@@H](C)C[C@@H](OC)[C@H]2O[C@@](O)([C@@H](C)C[C@H]2OC)C(=O)C(=O)N3CCCC[C@@H]3C(=O)O[C@H]([C@H](C)[C@@H](O)CC1=O)C(=C[C@@H]4CC[C@@H](O)[C@H](C4)OC)C ZDQSOHOQTUFQEM-XCXYXIJFSA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical class N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229960002129 cefixime Drugs 0.000 description 1
- OKBVVJOGVLARMR-QSWIMTSFSA-N cefixime Chemical compound S1C(N)=NC(C(=N\OCC(O)=O)\C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 OKBVVJOGVLARMR-QSWIMTSFSA-N 0.000 description 1
- 229960004261 cefotaxime Drugs 0.000 description 1
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 1
- 229960004755 ceftriaxone Drugs 0.000 description 1
- VAAUVRVFOQPIGI-SPQHTLEESA-N ceftriaxone Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(=O)C(=O)NN1C VAAUVRVFOQPIGI-SPQHTLEESA-N 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 229960002626 clarithromycin Drugs 0.000 description 1
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 229930182912 cyclosporin Natural products 0.000 description 1
- 229960000640 dactinomycin Drugs 0.000 description 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
- 229960000975 daunorubicin Drugs 0.000 description 1
- 229950010002 dectaflur Drugs 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- QSFOWAYMMZCQNF-UHFFFAOYSA-N delmopinol Chemical compound CCCC(CCC)CCCC1COCCN1CCO QSFOWAYMMZCQNF-UHFFFAOYSA-N 0.000 description 1
- 229960003854 delmopinol Drugs 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 229960004100 dirithromycin Drugs 0.000 description 1
- WLOHNSSYAXHWNR-NXPDYKKBSA-N dirithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H]2O[C@H](COCCOC)N[C@H]([C@@H]2C)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 WLOHNSSYAXHWNR-NXPDYKKBSA-N 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 229960004679 doxorubicin Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229960005167 everolimus Drugs 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229920006158 high molecular weight polymer Polymers 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229960000908 idarubicin Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229960004144 josamycin Drugs 0.000 description 1
- XJSFLOJWULLJQS-NGVXBBESSA-N josamycin Chemical compound CO[C@H]1[C@H](OC(C)=O)CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](N(C)C)[C@H](O[C@@H]2O[C@@H](C)[C@H](OC(=O)CC(C)C)[C@](C)(O)C2)[C@@H](C)O1 XJSFLOJWULLJQS-NGVXBBESSA-N 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 229960005287 lincomycin Drugs 0.000 description 1
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229960002757 midecamycin Drugs 0.000 description 1
- CFCUWKMKBJTWLW-BKHRDMLASA-N mithramycin Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@H]1O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@H](O)[C@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1 CFCUWKMKBJTWLW-BKHRDMLASA-N 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 description 1
- 229960001156 mitoxantrone Drugs 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 239000002159 nanocrystal Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229960003171 plicamycin Drugs 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229960005224 roxithromycin Drugs 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
- 229960002930 sirolimus Drugs 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960001294 spiramycin Drugs 0.000 description 1
- 235000019372 spiramycin Nutrition 0.000 description 1
- 229930191512 spiramycin Natural products 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229960001967 tacrolimus Drugs 0.000 description 1
- QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 description 1
- 229960003250 telithromycin Drugs 0.000 description 1
- LJVAJPDWBABPEJ-PNUFFHFMSA-N telithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)[C@@H](C)C(=O)O[C@@H]([C@]2(OC(=O)N(CCCCN3C=C(N=C3)C=3C=NC=CC=3)[C@@H]2[C@@H](C)C(=O)[C@H](C)C[C@@]1(C)OC)C)CC)[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O LJVAJPDWBABPEJ-PNUFFHFMSA-N 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- GBNXLQPMFAUCOI-UHFFFAOYSA-H tetracalcium;oxygen(2-);diphosphate Chemical compound [O-2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GBNXLQPMFAUCOI-UHFFFAOYSA-H 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 description 1
- 229960004059 tylosin Drugs 0.000 description 1
- 235000019375 tylosin Nutrition 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C19/00—Dental auxiliary appliances
- A61C19/06—Implements for therapeutic treatment
- A61C19/063—Medicament applicators for teeth or gums, e.g. treatment with fluorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C19/00—Dental auxiliary appliances
- A61C19/06—Implements for therapeutic treatment
- A61C19/063—Medicament applicators for teeth or gums, e.g. treatment with fluorides
- A61C19/066—Bleaching devices; Whitening agent applicators for teeth, e.g. trays or strips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/87—Application Devices; Containers; Packaging
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Inorganic Chemistry (AREA)
- Dentistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The disclosure relates to a method for treating or preventing periodontal disease, such as gingivitis or periodontitis. The method may comprise providing an antimicrobial composition disposed within a reservoir, the reservoir being fluidly connected to an exterior surface of an applicator having a frictional stress value sufficient to cause mechanical displacement of a biofilm present on an oral cavity surface; dispensing said antimicrobial composition through said applicator onto said exterior surface of said applicator; applying the antimicrobial composition to the oral cavity surface; and rubbing said applicator onto said oral cavity surface and exerting pressure towards said oral cavity surface.
Description
2 PCT/CA2013/000314 PREVENTING OR TREATING PERIODONTAL DISEASE
FIELD OF THE DISCLOSURE
The disclosure relates generally to preventing or treating periodontal disease, specifically but not exclusively to devices and antimicrobial compositions in methods and uses for preventing or treating periodontal disease.
BACKGROUND OF THE DISCLOSURE
Periodontal diseases, such as gingivitis and periodontitis, can lead to tooth loss if left untreated. Treatments often require visits to a dental office. Therefore, a need exists for treatments that can be used on a more routine basis outside of a dental office.
SUMMARY OF THE DISCLOSURE
Disclosed herein is a device and method for applying a brightening or antimicrobial composition to a tooth and/or gums for preventing or treating periodontal disease. The device is portable and can be used outside of a dental office. Preferably, the device applies a certain frictional stress upon a tooth and/or gums. More preferably, the device applies a frictional stress value that allows mechanical displacement of a biofilm present on the surface of a tooth. Even more preferably, the device applies a frictional stress value that allows mechanical displacement of a pellicle layer present on the surface of a tooth, but does not induce damage to the tooth enamel. Also disclosed herein are teeth brightening and antimicrobial compositions for use in conjunction with the device. In certain embodiments, the composition of the disclosure has both teeth whitening and antimicrobial activity. Also disclosed herein are methods for preventing or treating periodontal disease, and uses of the antimicrobial composition and devices for preventing or treating periodontal disease.
In one aspect, there is provided a device comprising a reservoir fluidly connected to an applicator, the applicator having a frictional stress value sufficient to cause mechanical displacement of a biofilm present on a surface of a tooth and/or gum. The applicator may comprise pores having a diameter of 0.1-1000 m, often but not always in conjunction with the above-indicated frictional stress value. A brightening or antimicrobial composition may be disposed in the reservoir. In some embodiments, the brightening or antimicrobial composition is present in an amount ranging from 2-6 ml. The device may comprise an activator configured to dispense the tooth brightening or antimicrobial composition from the reservoir onto an exterior surface of the applicator.
In some embodiments, the exterior surface of the applicator has a surface area of up to 4-100 MM2 .
In some embodiments, the applicator comprises a sponge. In some embodiments, the applicator comprises a silicone tip. In some embodiments, the applicator comprises a sponge and the sponge may include pores of sufficient diameter and connectivity for the hydroxyapatite to be transported through the sponge onto an exterior surface of the sponge.
In some embodiments, the brightening or antimicrobial composition comprises a source of peroxide. In some embodiments, the brightening or antimicrobial composition includes hydroxyapatite, such as where the hydroxyapatite has a particle size ranging from 10 to 200 nm.
In another aspect, there is provided a method for teeth brightening. The method may comprise the steps of a) providing a brightening composition disposed within a cylindrical reservoir, the cylindrical reservoir being fluidly connected to an exterior surface of an applicator having a frictional stress value sufficient to cause mechanical displacement of a biofilm present on a surface of the tooth, or comprising pores having a diameter of 0.1-1000 or both, b) dispensing the brightening composition through the applicator onto the exterior surface of the applicator, and c) applying the brightening composition onto a tooth.
In some embodiments, the brightening or antimicrobial composition is applied manually by rubbing the applicator onto a tooth and exerting pressure towards the tooth.
In a further aspect, the disclosure relates to a method for treating or preventing periodontal disease, such as gingivitis or periodontitis. The method may comprise the steps of a) providing a composition disposed within a reservoir, the reservoir being fluidly connected to an exterior surface of an applicator having a frictional stress value sufficient to cause mechanical displacement of a biofilm present on an oral cavity surface, or comprising pores having a diameter of 0.1-1000 IAM, or both, b) dispensing the composition through the applicator onto the exterior surface of the applicator, and c) applying the composition to the oral cavity surface. In some embodiments, the oral cavity surface is a tooth and/or gums.
In certain embodiments, the method for treating or preventing periodontal disease, such as gingivitis or periodontitis, comprises applying a composition comprising peroxide such as hydrogen peroxide and/or hydroxyapatite. The composition may comprise an antimicrobial agent such as an antibiotic or antiviral agent. Exemplary antibiotic agents that may be included in the composition include tetracycline, doxycycline, minocycline, amoxicillin and azithromycin.
In the method for treating gingivitis or periodontitis, the composition may be applied to the oral cavity surface, such as teeth and/or gums, at least once daily or at least once weekly. In particular embodiments, the composition is applied to the gums and/or the tooth/gum junction.
From another aspect, there is provided a method for preventing or treating periodontal disease, comprising: providing an antimicrobial composition disposed within a reservoir, the reservoir being fluidly connected to an exterior surface of an applicator having a frictional stress value sufficient to cause mechanical displacement of a biofilm present on an oral cavity surface; dispensing said antimicrobial composition through said applicator onto said exterior surface of said applicator; applying the antimicrobial composition to the oral cavity surface; and rubbing said applicator onto said oral cavity surface and exerting pressure towards said oral cavity surface. In certain embodiments, rubbing said applicator onto said
FIELD OF THE DISCLOSURE
The disclosure relates generally to preventing or treating periodontal disease, specifically but not exclusively to devices and antimicrobial compositions in methods and uses for preventing or treating periodontal disease.
BACKGROUND OF THE DISCLOSURE
Periodontal diseases, such as gingivitis and periodontitis, can lead to tooth loss if left untreated. Treatments often require visits to a dental office. Therefore, a need exists for treatments that can be used on a more routine basis outside of a dental office.
SUMMARY OF THE DISCLOSURE
Disclosed herein is a device and method for applying a brightening or antimicrobial composition to a tooth and/or gums for preventing or treating periodontal disease. The device is portable and can be used outside of a dental office. Preferably, the device applies a certain frictional stress upon a tooth and/or gums. More preferably, the device applies a frictional stress value that allows mechanical displacement of a biofilm present on the surface of a tooth. Even more preferably, the device applies a frictional stress value that allows mechanical displacement of a pellicle layer present on the surface of a tooth, but does not induce damage to the tooth enamel. Also disclosed herein are teeth brightening and antimicrobial compositions for use in conjunction with the device. In certain embodiments, the composition of the disclosure has both teeth whitening and antimicrobial activity. Also disclosed herein are methods for preventing or treating periodontal disease, and uses of the antimicrobial composition and devices for preventing or treating periodontal disease.
In one aspect, there is provided a device comprising a reservoir fluidly connected to an applicator, the applicator having a frictional stress value sufficient to cause mechanical displacement of a biofilm present on a surface of a tooth and/or gum. The applicator may comprise pores having a diameter of 0.1-1000 m, often but not always in conjunction with the above-indicated frictional stress value. A brightening or antimicrobial composition may be disposed in the reservoir. In some embodiments, the brightening or antimicrobial composition is present in an amount ranging from 2-6 ml. The device may comprise an activator configured to dispense the tooth brightening or antimicrobial composition from the reservoir onto an exterior surface of the applicator.
In some embodiments, the exterior surface of the applicator has a surface area of up to 4-100 MM2 .
In some embodiments, the applicator comprises a sponge. In some embodiments, the applicator comprises a silicone tip. In some embodiments, the applicator comprises a sponge and the sponge may include pores of sufficient diameter and connectivity for the hydroxyapatite to be transported through the sponge onto an exterior surface of the sponge.
In some embodiments, the brightening or antimicrobial composition comprises a source of peroxide. In some embodiments, the brightening or antimicrobial composition includes hydroxyapatite, such as where the hydroxyapatite has a particle size ranging from 10 to 200 nm.
In another aspect, there is provided a method for teeth brightening. The method may comprise the steps of a) providing a brightening composition disposed within a cylindrical reservoir, the cylindrical reservoir being fluidly connected to an exterior surface of an applicator having a frictional stress value sufficient to cause mechanical displacement of a biofilm present on a surface of the tooth, or comprising pores having a diameter of 0.1-1000 or both, b) dispensing the brightening composition through the applicator onto the exterior surface of the applicator, and c) applying the brightening composition onto a tooth.
In some embodiments, the brightening or antimicrobial composition is applied manually by rubbing the applicator onto a tooth and exerting pressure towards the tooth.
In a further aspect, the disclosure relates to a method for treating or preventing periodontal disease, such as gingivitis or periodontitis. The method may comprise the steps of a) providing a composition disposed within a reservoir, the reservoir being fluidly connected to an exterior surface of an applicator having a frictional stress value sufficient to cause mechanical displacement of a biofilm present on an oral cavity surface, or comprising pores having a diameter of 0.1-1000 IAM, or both, b) dispensing the composition through the applicator onto the exterior surface of the applicator, and c) applying the composition to the oral cavity surface. In some embodiments, the oral cavity surface is a tooth and/or gums.
In certain embodiments, the method for treating or preventing periodontal disease, such as gingivitis or periodontitis, comprises applying a composition comprising peroxide such as hydrogen peroxide and/or hydroxyapatite. The composition may comprise an antimicrobial agent such as an antibiotic or antiviral agent. Exemplary antibiotic agents that may be included in the composition include tetracycline, doxycycline, minocycline, amoxicillin and azithromycin.
In the method for treating gingivitis or periodontitis, the composition may be applied to the oral cavity surface, such as teeth and/or gums, at least once daily or at least once weekly. In particular embodiments, the composition is applied to the gums and/or the tooth/gum junction.
From another aspect, there is provided a method for preventing or treating periodontal disease, comprising: providing an antimicrobial composition disposed within a reservoir, the reservoir being fluidly connected to an exterior surface of an applicator having a frictional stress value sufficient to cause mechanical displacement of a biofilm present on an oral cavity surface; dispensing said antimicrobial composition through said applicator onto said exterior surface of said applicator; applying the antimicrobial composition to the oral cavity surface; and rubbing said applicator onto said oral cavity surface and exerting pressure towards said oral cavity surface. In certain embodiments, rubbing said applicator onto said
3 oral cavity surface and exerting pressure towards said oral cavity surface occurs at the same time as, before, or after applying the antimicrobial composition to the oral cavity surface. The method may include a further step of applying new antimicrobial composition to the oral cavity surface following rubbing said applicator onto said oral cavity surface and exerting pressure towards said oral cavity surface. The application of the antimicrobial composition may be as a flow of composition from the reservoir to the exterior surface of the reservoir.
The flow may be continuous or otherwise.
From another aspect, there is provided a method for preventing or treating periodontal disease, comprising: mechanically displacing a biofilm on an oral cavity surface; and applying an antimicrobial composition to the oral cavity surface. In certain embodiments, applying the antimicrobial composition comprises contacting the oral cavity surface with an exterior surface of an applicator fluidly connected to a reservoir containing the antimicrobial composition. In certain embodiments, mechanically displacing the biofilm comprises rubbing said oral cavity surface and exerting pressure towards said oral cavity surface with the external surface of the applicator, the external surface of the applicator having a frictional stress value sufficient to cause mechanical displacement of the biofilm on the oral cavity surface. In certain embodiments, the antimicrobial composition is applied to the oral cavity surface at the same time as, before, or after mechanically displacing the biofilm on the oral cavity surface. In certain embodiments, new antimicrobial composition is applied to the oral cavity surface after displacing the biofilm.
In certain embodiments of the aspects of the methods above, the antimicrobial composition may be broken down by enzymes on the oral cavity surface or in the saliva.
Therefore, providing fresh antimicrobial composition to the oral cavity surface, which may be a continuous or interrupted supply, can provide continued antimicrobial effect which may result in a faster treatment or more effective prevention of the periodontal disease.
The flow may be continuous or otherwise.
From another aspect, there is provided a method for preventing or treating periodontal disease, comprising: mechanically displacing a biofilm on an oral cavity surface; and applying an antimicrobial composition to the oral cavity surface. In certain embodiments, applying the antimicrobial composition comprises contacting the oral cavity surface with an exterior surface of an applicator fluidly connected to a reservoir containing the antimicrobial composition. In certain embodiments, mechanically displacing the biofilm comprises rubbing said oral cavity surface and exerting pressure towards said oral cavity surface with the external surface of the applicator, the external surface of the applicator having a frictional stress value sufficient to cause mechanical displacement of the biofilm on the oral cavity surface. In certain embodiments, the antimicrobial composition is applied to the oral cavity surface at the same time as, before, or after mechanically displacing the biofilm on the oral cavity surface. In certain embodiments, new antimicrobial composition is applied to the oral cavity surface after displacing the biofilm.
In certain embodiments of the aspects of the methods above, the antimicrobial composition may be broken down by enzymes on the oral cavity surface or in the saliva.
Therefore, providing fresh antimicrobial composition to the oral cavity surface, which may be a continuous or interrupted supply, can provide continued antimicrobial effect which may result in a faster treatment or more effective prevention of the periodontal disease.
4 In certain embodiments of the aspects of the methods above, the oral cavity surface is a gum surface, a tooth surface, or both gum and tooth surfaces. The gum or tooth surfaces can include periodontal pockets, in which case the method can further comprise pushing the antimicrobial composition into the periodontal pockets.
In certain embodiments of the aspects of the methods above, the antimicrobial composition comprises a peroxide source which can be hydrogen peroxide or urea peroxide.
In certain embodiments of the aspects of the methods above, the antimicrobial composition includes hydroxyapatite which may have a particle size ranging from 10-200 nm.
In certain embodiments, the antimicrobial composition comprises an antibiotic agent which may be selected from tetracycline, doxycycline, minocycline, amoxicillin and azithromycin. The antimicrobial composition may comprises one or more of: fluoride, triclosan, sodium bicarbonate, sweetening agent, detergent, chlorhexidine, cetylpyridinium, stannous fluoride and an amine fluoride.
In certain embodiments of the aspects of the methods above, the antimicrobial composition is applied to the oral cavity surface at least once daily, or at least once weekly.
In certain embodiments of the aspects of the methods above, a contact area between the exterior surface of the applicator and the oral cavity surface is about 0.25-400 mm2, about 4-100 mm2 or about 9-25 mm2. The exterior surface of the applicator may have a frictional stress value greater than about 0.001 1\l/mm2. The applicator may comprise pores having a diameter of 0.1-1000 p.m. The exterior surface of the applicator may be made of any suitable material or have any suitable texture for mechanically removing biofilm. For example, the applicator may comprise a sponge or silicone. The exterior surface of the applicator may comprise bristles.
From a yet further aspect, there is provided use of an antimicrobial composition for preventing or treating periodontal disease, wherein the antimicrobial composition is disposed
In certain embodiments of the aspects of the methods above, the antimicrobial composition comprises a peroxide source which can be hydrogen peroxide or urea peroxide.
In certain embodiments of the aspects of the methods above, the antimicrobial composition includes hydroxyapatite which may have a particle size ranging from 10-200 nm.
In certain embodiments, the antimicrobial composition comprises an antibiotic agent which may be selected from tetracycline, doxycycline, minocycline, amoxicillin and azithromycin. The antimicrobial composition may comprises one or more of: fluoride, triclosan, sodium bicarbonate, sweetening agent, detergent, chlorhexidine, cetylpyridinium, stannous fluoride and an amine fluoride.
In certain embodiments of the aspects of the methods above, the antimicrobial composition is applied to the oral cavity surface at least once daily, or at least once weekly.
In certain embodiments of the aspects of the methods above, a contact area between the exterior surface of the applicator and the oral cavity surface is about 0.25-400 mm2, about 4-100 mm2 or about 9-25 mm2. The exterior surface of the applicator may have a frictional stress value greater than about 0.001 1\l/mm2. The applicator may comprise pores having a diameter of 0.1-1000 p.m. The exterior surface of the applicator may be made of any suitable material or have any suitable texture for mechanically removing biofilm. For example, the applicator may comprise a sponge or silicone. The exterior surface of the applicator may comprise bristles.
From a yet further aspect, there is provided use of an antimicrobial composition for preventing or treating periodontal disease, wherein the antimicrobial composition is disposed
5 within a reservoir fluidly connected to an exterior surface of an applicator for dispensing the antimicrobial composition through the applicator onto the exterior surface of the applicator for applying the antimicrobial composition to the oral cavity surface, said exterior surface of the applicator having a frictional stress value sufficient to cause mechanical displacement of the biofilm when the applicator exterior surface is rubbed against the oral cavity surface and pressure is exerted towards said oral cavity surface.
From another aspect, there is provided use of an antimicrobial composition on an oral cavity surface with mechanical displacement of a biofilm on the oral cavity surface, for preventing or treating periodontal disease. There is also provided use of an antimicrobial composition on an oral cavity surface having a disrupted biofilm thereon, for preventing or treating periodontal disease. There is also provided use of an applicator for treating or preventing periodontal disease, wherein the applicator has an external surface for applying an antimicrobial composition to an oral cavity surface applicator, the external surface having a frictional stress value sufficient to cause mechanical displacement or disruption of the biofilm present on the oral surface cavity. In certain embodiments, the antimicrobial composition is disposed within a reservoir fluidly connected to an exterior surface of an applicator for contacting the oral cavity surface to apply the antimicrobial composition to the oral cavity surface, said applicator having a frictional stress value sufficient to cause mechanical displacement or disruption of the biofilm present on the oral surface cavity.
In certain embodiments of the above uses, the applicator and reservoir are arranged to deliver the antimicrobial composition onto the exterior surface of the applicator at the same time as, before, or after, mechanical displacement of the biofilm, to prevent or treat periodontal disease. In certain embodiments of the above uses, the oral cavity surface is a gum surface, a tooth surface, or both gum and tooth surfaces.
In certain embodiments of the above uses, the antimicrobial composition comprises a peroxide source, such as urea peroxide. In certain embodiments of the above uses, the
From another aspect, there is provided use of an antimicrobial composition on an oral cavity surface with mechanical displacement of a biofilm on the oral cavity surface, for preventing or treating periodontal disease. There is also provided use of an antimicrobial composition on an oral cavity surface having a disrupted biofilm thereon, for preventing or treating periodontal disease. There is also provided use of an applicator for treating or preventing periodontal disease, wherein the applicator has an external surface for applying an antimicrobial composition to an oral cavity surface applicator, the external surface having a frictional stress value sufficient to cause mechanical displacement or disruption of the biofilm present on the oral surface cavity. In certain embodiments, the antimicrobial composition is disposed within a reservoir fluidly connected to an exterior surface of an applicator for contacting the oral cavity surface to apply the antimicrobial composition to the oral cavity surface, said applicator having a frictional stress value sufficient to cause mechanical displacement or disruption of the biofilm present on the oral surface cavity.
In certain embodiments of the above uses, the applicator and reservoir are arranged to deliver the antimicrobial composition onto the exterior surface of the applicator at the same time as, before, or after, mechanical displacement of the biofilm, to prevent or treat periodontal disease. In certain embodiments of the above uses, the oral cavity surface is a gum surface, a tooth surface, or both gum and tooth surfaces.
In certain embodiments of the above uses, the antimicrobial composition comprises a peroxide source, such as urea peroxide. In certain embodiments of the above uses, the
6 antimicrobial composition includes hydroxyapatite, which may have a particle size ranging from 10-200 nm. The antimicrobial composition may comprise one or more of:
fluoride, triclosan, sodium bicarbonate, sweetening agent, detergent, chlorhexidine, cetylpyridinium, stannous fluoride and an amine fluoride. The antimicrobial composition may comprise an antimicrobial agent which may be an antibiotic agent, for example, tetracycline, doxycycline, minocycline, amoxicillin and azithromycin, or an antiviral agent.
In certain embodiments of the above uses, a contact area between the exterior surface of the applicator and the oral cavity surface is about 0.25-400 mm2, about 4-100 mm2 or about 9-25 mm2. The applicator may have a frictional stress value greater than about 0.001 N/mm2. The applicator may comprise pores having a diameter of 0.1-1000 il.M. The exterior surface of the applicator may be made of any suitable material or have any suitable texture for mechanically removing biofilm. For example, the applicator may comprise a sponge or silicone. The exterior surface of the applicator may comprise bristles.
In certain embodiments of the above aspects, the antimicrobial composition comprises urea peroxide due to its ability to generate reactive oxygen species which can prevent or treat periodontal disease, and due to its lack of side effects. In particular, urea peroxide is less easily enzymatically degraded compared to hydrogen peroxide, and is better tolerated by the mucosa of the oral cavity. Furthermore, urea peroxide does not stain teeth, does not alter taste, and does not induce sensitivity, which can occur with other antimicrobial agents such as chlorhexidine.
BRIEF DESCRIPTION OF THE DRAWINGS
Further aspects and advantages of the present disclosure will become better understood with reference to the description in association with the following in which:
Figure 1 shows a device for applying a brightening or antimicrobial composition to a tooth and/or gums.
fluoride, triclosan, sodium bicarbonate, sweetening agent, detergent, chlorhexidine, cetylpyridinium, stannous fluoride and an amine fluoride. The antimicrobial composition may comprise an antimicrobial agent which may be an antibiotic agent, for example, tetracycline, doxycycline, minocycline, amoxicillin and azithromycin, or an antiviral agent.
In certain embodiments of the above uses, a contact area between the exterior surface of the applicator and the oral cavity surface is about 0.25-400 mm2, about 4-100 mm2 or about 9-25 mm2. The applicator may have a frictional stress value greater than about 0.001 N/mm2. The applicator may comprise pores having a diameter of 0.1-1000 il.M. The exterior surface of the applicator may be made of any suitable material or have any suitable texture for mechanically removing biofilm. For example, the applicator may comprise a sponge or silicone. The exterior surface of the applicator may comprise bristles.
In certain embodiments of the above aspects, the antimicrobial composition comprises urea peroxide due to its ability to generate reactive oxygen species which can prevent or treat periodontal disease, and due to its lack of side effects. In particular, urea peroxide is less easily enzymatically degraded compared to hydrogen peroxide, and is better tolerated by the mucosa of the oral cavity. Furthermore, urea peroxide does not stain teeth, does not alter taste, and does not induce sensitivity, which can occur with other antimicrobial agents such as chlorhexidine.
BRIEF DESCRIPTION OF THE DRAWINGS
Further aspects and advantages of the present disclosure will become better understood with reference to the description in association with the following in which:
Figure 1 shows a device for applying a brightening or antimicrobial composition to a tooth and/or gums.
7 Figure 2 shows a device for applying a brightening or an antimicrobial composition to a tooth and/or gums, wherein the device has an applicator comprising a sponge.
Figure 3 depicts the antibacterial activity of the composition in a disc diffusion assay. The antibacterial activity of the composition is compared to peroxide positive controls as well as saline negative control.
Figure 4 depicts the inhibition of bacterial growth around the disc in the assay of Figure 3.
DETAILED DESCRIPTION
This disclosure is not limited in its application to the details of construction and the arrangement of components set forth in the following description or illustrated in the drawings. The disclosure is capable of other embodiments and of being practiced or of being carried out in various ways. Also, the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. The use of "including", "comprising", or "having", "containing", "involving" and variations thereof herein, is meant to encompass the items listed thereafter as well as, optionally, additional items. The term "and/or" where used herein is to be taken as specific disclosure of each of the two specified features or components with or without the other. For example "A and/or B" is to be taken as specific disclosure of each of (i) A, (ii) B and (iii) A and B, just as if each is set out individually herein. In the following description, the same numerical references refer to similar elements. In the drawings, like reference characters designate like or similar parts.
Devices and methods Described herein is a device 10 and method for applying a brightening or antimicrobial composition to a tooth and/or gums. Preferred devices comprise a reservoir 25 fluidly connected to an applicator 30. Preferably, the applicator is optimized with regard to its mechanical performance so as to induce a certain frictional stress upon a tooth and/or gums.
An advantageous choice of frictional stress allows effective tooth brightening or prevention or treatment of periodontal disease, such as gingivitis or periodontitis, but without damaging
Figure 3 depicts the antibacterial activity of the composition in a disc diffusion assay. The antibacterial activity of the composition is compared to peroxide positive controls as well as saline negative control.
Figure 4 depicts the inhibition of bacterial growth around the disc in the assay of Figure 3.
DETAILED DESCRIPTION
This disclosure is not limited in its application to the details of construction and the arrangement of components set forth in the following description or illustrated in the drawings. The disclosure is capable of other embodiments and of being practiced or of being carried out in various ways. Also, the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. The use of "including", "comprising", or "having", "containing", "involving" and variations thereof herein, is meant to encompass the items listed thereafter as well as, optionally, additional items. The term "and/or" where used herein is to be taken as specific disclosure of each of the two specified features or components with or without the other. For example "A and/or B" is to be taken as specific disclosure of each of (i) A, (ii) B and (iii) A and B, just as if each is set out individually herein. In the following description, the same numerical references refer to similar elements. In the drawings, like reference characters designate like or similar parts.
Devices and methods Described herein is a device 10 and method for applying a brightening or antimicrobial composition to a tooth and/or gums. Preferred devices comprise a reservoir 25 fluidly connected to an applicator 30. Preferably, the applicator is optimized with regard to its mechanical performance so as to induce a certain frictional stress upon a tooth and/or gums.
An advantageous choice of frictional stress allows effective tooth brightening or prevention or treatment of periodontal disease, such as gingivitis or periodontitis, but without damaging
8 the enamel or another portion of the tooth or gums. However, the frictional stress should be sufficient to mechanically displace a biofilm and/or pellicle layer (partially or completely) from the surface of a tooth and/or gums. "Pellicle" as used herein is a layer of salivary glycoproteins that adhere to the surface of a tooth and/or gums. "Biofilm" as used herein is a substance that adheres to the surface of the tooth and/or gums or the pellicle layer, and may include additional components, for example substances excreted from bacteria.
For example, a biofilm may include a sessile community of cells that may be microbioally derived and that are attached to a substrate or to each other. These adherent cells are often embedded in a matrix of extracellular polymeric substances that they have produced, and that exhibit an altered phenotype with respect to growth rate and gene transcription.
The device 10 places an applicator 30 in contact with the surface of a tooth and/or gums and delivers a tooth brightening or antimicrobial composition through the applicator 30 onto the surface of a tooth and/or gums.
The device 10 preferably has a reservoir 25 for storing the brightening or antimicrobial composition and an applicator 30 that is fluidly connected to the reservoir 25 via a feeder 42.
The device 10 may be portable and in the shape of a pencil, pen or liquid stick. In one embodiment, the device 10 includes more than one applicator 30 that may be removably engaged with the device 10. In an embodiment wherein the device 10 is a shaped like a pen or a pencil, the applicator 30 may be retractable. The brightening or antimicrobial composition described herein may be housed directly within the reservoir 25 in the device 10 or may be supplied in a removable cartridge (not shown) within the reservoir 25 that may be replaced or refilled. The device may also comprise a cap 45.
It is believed that the performance of the applicator 30 with regards to tooth brightening or antimicrobial activity is enhanced by the friction or abrasion induced by the applicator 30 upon a tooth and/or gums. The friction or abrasion induced by the applicator 30 upon a tooth and/or gums can be defined in terms of frictional stress. The frictional stress value can be defined as the force exerted upon a reference surface per unit area of real contact, which is
For example, a biofilm may include a sessile community of cells that may be microbioally derived and that are attached to a substrate or to each other. These adherent cells are often embedded in a matrix of extracellular polymeric substances that they have produced, and that exhibit an altered phenotype with respect to growth rate and gene transcription.
The device 10 places an applicator 30 in contact with the surface of a tooth and/or gums and delivers a tooth brightening or antimicrobial composition through the applicator 30 onto the surface of a tooth and/or gums.
The device 10 preferably has a reservoir 25 for storing the brightening or antimicrobial composition and an applicator 30 that is fluidly connected to the reservoir 25 via a feeder 42.
The device 10 may be portable and in the shape of a pencil, pen or liquid stick. In one embodiment, the device 10 includes more than one applicator 30 that may be removably engaged with the device 10. In an embodiment wherein the device 10 is a shaped like a pen or a pencil, the applicator 30 may be retractable. The brightening or antimicrobial composition described herein may be housed directly within the reservoir 25 in the device 10 or may be supplied in a removable cartridge (not shown) within the reservoir 25 that may be replaced or refilled. The device may also comprise a cap 45.
It is believed that the performance of the applicator 30 with regards to tooth brightening or antimicrobial activity is enhanced by the friction or abrasion induced by the applicator 30 upon a tooth and/or gums. The friction or abrasion induced by the applicator 30 upon a tooth and/or gums can be defined in terms of frictional stress. The frictional stress value can be defined as the force exerted upon a reference surface per unit area of real contact, which is
9 expressed as a = T/A = N/A. In this equation, T is the tangential force, A
the area of contact, the coefficient of friction, and N the vertical force.
Without being bound by theory, it is believed that the frictional stress of an applicator 30 is of particular importance, as it indicates the efficiency with which the mechanical energy provided by the user is transferred to the surface of a tooth and/or gums. The frictional stress can cause mechanical displacement of biofilm. When an applicator has a low frictional stress value, the energy supplied by the user is dissipated in other ways, for example, through the applicator itself, resulting in the applicator deforming.
Frictional stress values greater than 0.001 N mm-2 are advantageous. More preferably, the frictional stress values are from 0.001-0.01 N mm-2, 0.01-0.1 N mm-2, 0.1 to 0.2 N mm-2, 0.2-0.3 N mm-2, 0.3-0.4 N mm-2, 0.4-0.5 N mm-2, 0.5-0.6 N mm-2, 0.6-0.7 N mm-2, 0.7-0.8 N
mm-2, 0.8-0.9 N mm-2, or 0.9-1 N mm-2. In certain embodiments, the frictional stress values may be from 1-1.5 N mm-2, 1.5-2 N mm-2, or even from 2-2.5 or 2.5-3 N mm-2.
The frictional stress value of an applicator 30 may be measured using methods known in the art. One example uses a Plint dual axis reciprocating rig (such as model TE75R, MRPRA
RUBBER CONSULTANTS). The device 10 is clamped to the load arm of the reciprocating rig and the angle of the device relative to the reference surface is adapted to maximize the contact area of an exterior surface of the applicator 30. The clamping arrangement should be set to provide a consumer realistic normal force, N, on the applicator 30 of about 3 N. The coefficient of friction is then measured between the applicator 30 and a reference surface that is similar to the surface of a tooth and/or gums. The applicator 30 is measured wet using a brightening or antimicrobial composition as given in Example 1. The coefficient of friction is measured over the central 10 mm of four traverses of 20 mm in both the forward and reverse direction at a speed of 1 mm s H and an average value calculated. Measurements with the applicator 30 in final measuring position are repeated three times to check reproducibility.
In some embodiments, the applicator (e.g., 30) comprises a sponge 40. The sponge 40 includes pores 41 that are fluidly connected to a feeder (e.g., 42) which receives the brightening or antimicrobial composition from reservoir (e.g., 25).
Preferably, the sponge 40 is comprised of pores 41 having a mean diameter of about 0.1-1000 pm. More preferably, the pores have a mean diameter of about 0.1-10011m, 100-200 pm, 200-300 im, 300-500 ilm, 500-750 tim or 750-1000 !Am.
The sponge 40 may be made of synthetic or man-made or natural materials such as felt, foam, polyethylene, nylon, silicone, etc. Preferably, the sponge 40 is made of a material resistant to peroxide-induced corrosion.
In some embodiments, the applicator comprises a sponge 40 made of nylon such as flocked nylon. Figure 2 illustrates an exemplary embodiment in which the applicator comprises a sponge 40. As shown in Figure 2, the sponge 40 is optimized with regard to having pores 41 of sufficient diameter and connectivity for particles (e.g., hydroxyapatite particles, as described below) in the brightening or antimicrobial composition to be transported through the pores 41 onto an exterior surface of the applicator 30. BrightOne (www.blancone.it) sold by International Dental Supply includes a sponge having the above described characteristics.
The contact area between the exterior surface of the applicator 30 and a surface of a tooth and/or gums preferably is from 0.25-400 mm2, 4-100 mm2, or 9-25 mm2. Such a contact area ensures optimal mechanical removal of biofilm and allows for efficient application of the brightening or antimicrobial composition onto the surface of a tooth and/or gums.
Measurements of the contact area of the exterior surface of the applicator 30 can be carried out with a dry applicator 30. The dry applicator 30 is wetted by pressing it against a pad containing a brightening or antimicrobial composition and then clamping the device 10 to the load arm of a plint dual axis reciprocating rig (such as model TE75R, MRPRA
RUBBER
CONSULTANTS). A mark on a contact surface that is representative of the contact area of the exterior surface of the applicator 30 is obtained by controlled lowering and rising of the plint load arm towards and away from the reference surface. The angle of the device relative to the reference surface is adapted to maximize the contact area between the applicator 30 and the reference surface. The contact time should be approximately 1 s while a normal load of about 3 N should be applied on the application device. The contact area can then be calculated from the mean length and width of the mark determined using a magnifying lens with a graticule. Measurements with the applicator 30 in final measuring position are repeated three times to check reproducibility.
The device 10 may dispense the brightening or antimicrobial composition from the reservoir 25 onto an exterior surface of the applicator 30 through the feeder 42 via capillary action, such as in a flow through pen, or by exerting pressure on the applicator 30 by pushing the device 10 onto a surface of a tooth and/or gums, or via an activator, such as a mechanical piston with a click mechanism, a twist button and ratchet mechanism, or a push button mechanism, or through a vacuum method of ejection, or through other mechanical means that transfer the composition from the reservoir 25 to an oral cavity surface in need of treatment.
The activator may be positioned on a first end or side wall of the device 10.
In certain embodiments, the device has an activator comprising a push button.
With the push button activator, the user pushes the button located on a first end or side wall of the device
the area of contact, the coefficient of friction, and N the vertical force.
Without being bound by theory, it is believed that the frictional stress of an applicator 30 is of particular importance, as it indicates the efficiency with which the mechanical energy provided by the user is transferred to the surface of a tooth and/or gums. The frictional stress can cause mechanical displacement of biofilm. When an applicator has a low frictional stress value, the energy supplied by the user is dissipated in other ways, for example, through the applicator itself, resulting in the applicator deforming.
Frictional stress values greater than 0.001 N mm-2 are advantageous. More preferably, the frictional stress values are from 0.001-0.01 N mm-2, 0.01-0.1 N mm-2, 0.1 to 0.2 N mm-2, 0.2-0.3 N mm-2, 0.3-0.4 N mm-2, 0.4-0.5 N mm-2, 0.5-0.6 N mm-2, 0.6-0.7 N mm-2, 0.7-0.8 N
mm-2, 0.8-0.9 N mm-2, or 0.9-1 N mm-2. In certain embodiments, the frictional stress values may be from 1-1.5 N mm-2, 1.5-2 N mm-2, or even from 2-2.5 or 2.5-3 N mm-2.
The frictional stress value of an applicator 30 may be measured using methods known in the art. One example uses a Plint dual axis reciprocating rig (such as model TE75R, MRPRA
RUBBER CONSULTANTS). The device 10 is clamped to the load arm of the reciprocating rig and the angle of the device relative to the reference surface is adapted to maximize the contact area of an exterior surface of the applicator 30. The clamping arrangement should be set to provide a consumer realistic normal force, N, on the applicator 30 of about 3 N. The coefficient of friction is then measured between the applicator 30 and a reference surface that is similar to the surface of a tooth and/or gums. The applicator 30 is measured wet using a brightening or antimicrobial composition as given in Example 1. The coefficient of friction is measured over the central 10 mm of four traverses of 20 mm in both the forward and reverse direction at a speed of 1 mm s H and an average value calculated. Measurements with the applicator 30 in final measuring position are repeated three times to check reproducibility.
In some embodiments, the applicator (e.g., 30) comprises a sponge 40. The sponge 40 includes pores 41 that are fluidly connected to a feeder (e.g., 42) which receives the brightening or antimicrobial composition from reservoir (e.g., 25).
Preferably, the sponge 40 is comprised of pores 41 having a mean diameter of about 0.1-1000 pm. More preferably, the pores have a mean diameter of about 0.1-10011m, 100-200 pm, 200-300 im, 300-500 ilm, 500-750 tim or 750-1000 !Am.
The sponge 40 may be made of synthetic or man-made or natural materials such as felt, foam, polyethylene, nylon, silicone, etc. Preferably, the sponge 40 is made of a material resistant to peroxide-induced corrosion.
In some embodiments, the applicator comprises a sponge 40 made of nylon such as flocked nylon. Figure 2 illustrates an exemplary embodiment in which the applicator comprises a sponge 40. As shown in Figure 2, the sponge 40 is optimized with regard to having pores 41 of sufficient diameter and connectivity for particles (e.g., hydroxyapatite particles, as described below) in the brightening or antimicrobial composition to be transported through the pores 41 onto an exterior surface of the applicator 30. BrightOne (www.blancone.it) sold by International Dental Supply includes a sponge having the above described characteristics.
The contact area between the exterior surface of the applicator 30 and a surface of a tooth and/or gums preferably is from 0.25-400 mm2, 4-100 mm2, or 9-25 mm2. Such a contact area ensures optimal mechanical removal of biofilm and allows for efficient application of the brightening or antimicrobial composition onto the surface of a tooth and/or gums.
Measurements of the contact area of the exterior surface of the applicator 30 can be carried out with a dry applicator 30. The dry applicator 30 is wetted by pressing it against a pad containing a brightening or antimicrobial composition and then clamping the device 10 to the load arm of a plint dual axis reciprocating rig (such as model TE75R, MRPRA
RUBBER
CONSULTANTS). A mark on a contact surface that is representative of the contact area of the exterior surface of the applicator 30 is obtained by controlled lowering and rising of the plint load arm towards and away from the reference surface. The angle of the device relative to the reference surface is adapted to maximize the contact area between the applicator 30 and the reference surface. The contact time should be approximately 1 s while a normal load of about 3 N should be applied on the application device. The contact area can then be calculated from the mean length and width of the mark determined using a magnifying lens with a graticule. Measurements with the applicator 30 in final measuring position are repeated three times to check reproducibility.
The device 10 may dispense the brightening or antimicrobial composition from the reservoir 25 onto an exterior surface of the applicator 30 through the feeder 42 via capillary action, such as in a flow through pen, or by exerting pressure on the applicator 30 by pushing the device 10 onto a surface of a tooth and/or gums, or via an activator, such as a mechanical piston with a click mechanism, a twist button and ratchet mechanism, or a push button mechanism, or through a vacuum method of ejection, or through other mechanical means that transfer the composition from the reservoir 25 to an oral cavity surface in need of treatment.
The activator may be positioned on a first end or side wall of the device 10.
In certain embodiments, the device has an activator comprising a push button.
With the push button activator, the user pushes the button located on a first end or side wall of the device
10, which causes the transfer of the composition from the reservoir 25 through the feeder 42 and onto the exterior surface of the applicator 30. More preferably, push button activator has an arrangement that allows partitioning of the brightening composition. This can be achieved, for example, via a catch arresting mechanism connected to the push button activator. From the sound of the catch upon actuating the push button activator, the user is able to recognize that a single dose of the brightening or antimicrobial composition has been dispensed onto the exterior surface of the applicator 30.
Once the composition is positioned onto the exterior surface of the applicator 30, a user applies the composition to a tooth and/or gum surface by manually rubbing the applicator 30 onto the tooth and/or gums and exerting pressure towards the tooth and/or gums. Preferably, manually rubbing the applicator 30 onto the tooth and/or gums and exerting pressure towards the tooth and/or gums causes mechanical displacement of a biofilm from the tooth and/or gum surface.
A set of instructions can be provided to the user to describe how to apply the composition from the device 10 onto the teeth and/or gums.
In certain embodiments, the reservoir 25 is made of peroxide-resistant materials. In one embodiment, the reservoir 25 is made from fluoropolymers, polypropylene, polyethylene, or other such polymers that are compatible with the ingredients of the composition of the present disclosure.
Compositions The devices of the disclosure may be used for delivering a variety of compositions in particular to the teeth and gums. In some embodiments, the devices deliver compositions that brighten teeth and/or have antimicrobial properties. The compositions described herein may be used for the treatment of periodontal disease such as gingivitis or periodontitis.
Compositions with antimicrobial activity may also have teeth whitening activity.
The term "preventing" is art-recognized, and when used in relation to a condition, such as a periodontal disease such as periodontitis, is well understood in the art, and includes administration of a composition which reduces the frequency of, or delays the onset of, symptoms of a medical condition in a subject relative to a subject which does not receive the composition. Thus, prevention of periodontitis includes, for example, reducing the inflammation or infection of the ligaments and bones that support the teeth in a population of patients receiving a prophylactic treatment relative to an untreated control population.
The term "prophylactic" treatment is art-recognized and refers to administration of a drug to a host. If it is administered prior to clinical manifestation of the unwanted condition (e.g., disease or other unwanted state of the host animal) then the treatment is prophylactic, i.e., it protects the host against developing the unwanted condition.
"Treating" a condition or disease refers to curing as well as ameliorating at least one symptom of the condition or disease.
The composition used herein is comprised of a gel carrier and at least one brightening agent dispersed throughout the gel carrier. The brightening agent or antimicrobial agent may be dissolved in the gel carrier or simply dispersed homogeneously in the carrier as an insoluble -- suspended solid particulate.
The composition may comprise a peroxide source. Hydrogen peroxide is a powerful oxidizing agent. Typically, the concentration of hydrogen peroxide in the present composition is from about 0.001-10% by weight of the composition, such as 1-7%
or 4-6%.
Urea hydrogen peroxide (also known as urea peroxide, carbamide peroxide or percarbamide) -- may also be used. Typically, the concentration of urea peroxide in the present composition is from about 0.003-30% by weight of the composition, such as about 1-25%, 10-20%
or 13-17%. The composition may comprise a bicarbonate salt such as sodium bicarbonate.
The gel carrier may contain any number of ingredients that increase the viscosity of the composition and may be present in an amount ranging from about 35-95%, or 45-70%, or 55--- 65% by weight of the composition. In certain embodiments, sufficient gel carrier is added to obtain a composition having a viscosity of about 10,000 to 200,000 cps, or about 30,000 to 150,000, or 50,000 to 120,000. The gel carrier may comprise one or more polymers.
Preferred polymers are high molecular weight polymers of acrylic acid such as Carbopol .
The gel carrier may also include cellulose derivatives (such as hydroxyethyl cellulose, -- carboxymethyl cellulose sodium, and methyl cellulose), gums (such as sodium alginate, carrageenan, xanthan gum, tragacanth gum, acacia gum, jellan gum, and native jellan gum), synthetic binders (such as polyvinyl alcohol, carboxyvinyl polymer, polyvinyl pyrrolidone, propylene glycol and polyethylene oxide), natural polyols (such as glycerin, mannitol, sorbitol and maltitol) and inorganic binders (such as silica gel, aluminum silica gel, bee gum, -- and Laponite). For example, the gel carrier may contain a polymer in combination with a synthetic binder and/or a natural polyol, such as 12-18% synthetic binder (e.g., propylene glycol), 40-50% natural polyol (e.g., glycerin), and 0.5-4% of polymer (e.g., Carbopol).
In some embodiments, the composition comprises flavoring agents. Flavoring agents that are useful include essential oils as well as various flavoring aldehydes, esters, alcohols, and similar materials. Examples of the essential oils include oils of spearmint, peppermint, wintergreen, sassafras, clove, sage, eucalyptus, marjoram, cinnamon, lemon, lime, grapefruit, and orange. Also useful are such chemicals as menthol, carvone, and anethole, and synthetic flavors like Evercool, and derivatives of cyclic alpha-keto enamines. Of these, the most commonly employed are the oils of peppermint, spearmint and wintergreen. The flavoring agent is incorporated in the brightening liquid composition of the present disclosure at a concentration of about 0.05 to about 2%, or preferably about 0.1 to about 0.5%
by weight of the composition. A sweetening material may also be employed as a complement to the flavoring material. Suitable sweetening agents are water soluble and include sodium saccharin, sodium cyclamate, xylitol, perillartien, D-tryptophan, aspartame, dihydrochalcones and the like.
In some embodiments, the composition comprises a brightening particulate. The brightening particulates may comprise a form of calcium phosphate. The calcium phosphate may have a structure selected from tetracalcium phosphate, amorphous calcium phosphate, alpha-tricalcium phosphate, beta-tricalcium phosphate and hydroxyapatite (Ca5 (OH)(PO4)3). The calcium phosphate may be a substantially aqueous insoluble calcium phosphate and non-crystalline, poorly crystalline or crystalline form such as, for example, crystalline hydroxyapatite. Preferably, the composition includes nanoparticles of hydroxyapatite.
Hydroxyapatite has a similar physical structure as tooth enamel, and thus has a strong affinity to the tooth enamel surfaces, resulting in the hydroxyapatite particulates imparting a "natural" white appearance to the enamel surface. The hydroxylapatite crystals may also cause accumulation of an electrostatic charge, due to the pressure and friction exerted by the sponge, facilitating and amplifying the penetration of ions in the enamel structure. A large amount of the nanoparticles of hydroxyapatite could even percolate in the enamel and facilitate a deposition of calcium and calcium phosphate ions on the enamel.
The hydroxyapatite may also decrease the deleterious effects of peroxides and allow remineralization of the enamel. Preferably, hydroxyapatite is present in the composition of the present disclosure at a concentration of about 0.5-5%, or about 1-2% by weight of the composition. In some embodiments, hydroxyapatite particles can comprise aggregates of individual hydroxyapatite particles. For example, such aggregates can have a mean diameter of from about 100 nm to about 1000 nm, and comprise hydroxyapatite particles having a mean diameter of about 10 nm to about 200 nm.
In some embodiments, the composition further comprises one or more of fluoride, triclosan, detergent, clorhexidine, cetylpyridinium, stannous fluoride, and an amine fluoride. Examples of amine fluorides include olaflur (N'-octadecyltrimethylenediamine-N,N,N'-tris(2-ethanol)-dihydrofluoride) and dectaflur (9-octadecenylamine-hydrofluoride). Exemplary detergents include delmopinol, sodium lauryl sulfate (SLS), and cocoamidopropyl betaine (CAPB).
In certain embodiments, the composition further comprises an antimicrobial agent. For example, the antimicrobial agent may be selected from an antiviral agent or an antibiotic agent. Antibiotics include, for example, vancomycin, penicillin, amoxicillin, ampicillin, cefotaxime, ceftriaxone, cefixime, rifampinmetronidazole, doxycycline, tetracycline, minocycline, azithromycin, tacrolimus, cyclosporine, sirolimus, everolimus, ascomycin, erythromycin, clarithromycin, clindamycin, lincomycin, dirithromycin, josamycin, spiramycin, diacetyl-midecamycin, tylosin, roxithromycin, ABT-773, telithromycin, leucomycins, lincosamide, dactinomycin, daunorubicin, doxorubicin, idarubicin, anthracyclines, mitoxantrone, bleomycins, plicamycin, mitomycin and streptomycin.
In some embodiments, the composition comprises a stabilizing agent. The stabilizing agent utilized in the aqueous gel is present in an amount ranging from about 0.01%
to about 5% by weight of the aqueous gel. An amount of approximately 1% stabilizing agent is preferred.
The stabilizing agent is typically selected from aminocarboxylic acids and salts thereof.
Preferred stabilizers are selected from aminocarboxylic acids and alkali and/or alkali earth metal salts thereof. Suitable aminocarboxylic acids include trans-1,2-cyclohexylene dinitrilotetraacetic acid (CDTA), ethylenediamine tetraacetic acid (EDTA), N-(2-hydroxyethyl) ethylenediamine triacetic acid (HEDTA), Nitrilotriacetic acid (NTA), diethylene triamine pentaacetic acid (DTPA), triethylene tetraamine hexaacetic acid (TTHA), and ethyleneglycol bis (2-aminoethylether) tetraacetic acid (GEDTA).
In addition to the aforementioned components, a neutralizing agent may be added to the composition. The inorganic and organic neutralizing agents which may be employed are bases. Suitable bases include alkali metal hydroxides and ammonium hydroxide, carbonates, alkoxides, oxides, peroxides, superoxides, and water soluble organic amines.
Amino acids such as 13-alanine and lysine can also be used for neutralization and viscosity modification.
Preferred bases include sodium hydroxide, potassium hydroxide, ammonium hydroxide, triethanolamine (TEA), aminomethyl propanol (AMP), 2-amino-2-hydroxymethy1-1,3 -propanediol (Tromethamine), tetrahydroxypropyl ethylenediamine, and tris(hydroxymethypaminomethane (TRIS). In certain embodiments, the neutralizing agent will be used to obtain a brightening composition having a pH of about 4 to 10, or about 5 to 7, or about 5.5 to 6.5.
The following are non-limiting examples of aspects and embodiments of the present disclosure.
An exemplary composition was prepared by mixing the following components.
Components % content Propylene Glycol,-,.. 16%
Purified Water m-, 18%
Glycerin A--- 45%
Carbamide Peroxide ....-. 15%
Disodium EDTA,=-= 1%
CARBOPOL 940..- 2%
Sodium Hydroxide =-=. 0.5%
Nano-crystals Hydroxylapatite . 1.5%
Sodium Saccharine ---, 0.1%
Mint Flavoring ----, 0.2%
Evaluation of the antibacterial activity of the composition using a disc diffusion assay.
Nutrient medium was inoculated with fresh bacteria from the gum-teeth junction and cultured at 37 C with agitation. 24h later 500 4, of bacterial suspension were spread onto agar petri dishes, and sterile nylon discs of 8mm were placed on the plates.
15 vt.L of test solutions (saline, 1% H202 and 4.3% H202) or 5004 of the composition of Example 1 were applied on the disc, and the plates were incubated at 37 C for 24h. As shown in Figures 3 and 4, the composition of Example 1 displays a clear bactericidal activity on bacteria from gum-teeth junction as illustrated by the diameter of bacteria-free zone around the disc.
It should be appreciated that the disclosure is not limited to the particular embodiments described and illustrated herein but includes all modifications and variations falling within the scope of the disclosure as defined in the appended claims.
Once the composition is positioned onto the exterior surface of the applicator 30, a user applies the composition to a tooth and/or gum surface by manually rubbing the applicator 30 onto the tooth and/or gums and exerting pressure towards the tooth and/or gums. Preferably, manually rubbing the applicator 30 onto the tooth and/or gums and exerting pressure towards the tooth and/or gums causes mechanical displacement of a biofilm from the tooth and/or gum surface.
A set of instructions can be provided to the user to describe how to apply the composition from the device 10 onto the teeth and/or gums.
In certain embodiments, the reservoir 25 is made of peroxide-resistant materials. In one embodiment, the reservoir 25 is made from fluoropolymers, polypropylene, polyethylene, or other such polymers that are compatible with the ingredients of the composition of the present disclosure.
Compositions The devices of the disclosure may be used for delivering a variety of compositions in particular to the teeth and gums. In some embodiments, the devices deliver compositions that brighten teeth and/or have antimicrobial properties. The compositions described herein may be used for the treatment of periodontal disease such as gingivitis or periodontitis.
Compositions with antimicrobial activity may also have teeth whitening activity.
The term "preventing" is art-recognized, and when used in relation to a condition, such as a periodontal disease such as periodontitis, is well understood in the art, and includes administration of a composition which reduces the frequency of, or delays the onset of, symptoms of a medical condition in a subject relative to a subject which does not receive the composition. Thus, prevention of periodontitis includes, for example, reducing the inflammation or infection of the ligaments and bones that support the teeth in a population of patients receiving a prophylactic treatment relative to an untreated control population.
The term "prophylactic" treatment is art-recognized and refers to administration of a drug to a host. If it is administered prior to clinical manifestation of the unwanted condition (e.g., disease or other unwanted state of the host animal) then the treatment is prophylactic, i.e., it protects the host against developing the unwanted condition.
"Treating" a condition or disease refers to curing as well as ameliorating at least one symptom of the condition or disease.
The composition used herein is comprised of a gel carrier and at least one brightening agent dispersed throughout the gel carrier. The brightening agent or antimicrobial agent may be dissolved in the gel carrier or simply dispersed homogeneously in the carrier as an insoluble -- suspended solid particulate.
The composition may comprise a peroxide source. Hydrogen peroxide is a powerful oxidizing agent. Typically, the concentration of hydrogen peroxide in the present composition is from about 0.001-10% by weight of the composition, such as 1-7%
or 4-6%.
Urea hydrogen peroxide (also known as urea peroxide, carbamide peroxide or percarbamide) -- may also be used. Typically, the concentration of urea peroxide in the present composition is from about 0.003-30% by weight of the composition, such as about 1-25%, 10-20%
or 13-17%. The composition may comprise a bicarbonate salt such as sodium bicarbonate.
The gel carrier may contain any number of ingredients that increase the viscosity of the composition and may be present in an amount ranging from about 35-95%, or 45-70%, or 55--- 65% by weight of the composition. In certain embodiments, sufficient gel carrier is added to obtain a composition having a viscosity of about 10,000 to 200,000 cps, or about 30,000 to 150,000, or 50,000 to 120,000. The gel carrier may comprise one or more polymers.
Preferred polymers are high molecular weight polymers of acrylic acid such as Carbopol .
The gel carrier may also include cellulose derivatives (such as hydroxyethyl cellulose, -- carboxymethyl cellulose sodium, and methyl cellulose), gums (such as sodium alginate, carrageenan, xanthan gum, tragacanth gum, acacia gum, jellan gum, and native jellan gum), synthetic binders (such as polyvinyl alcohol, carboxyvinyl polymer, polyvinyl pyrrolidone, propylene glycol and polyethylene oxide), natural polyols (such as glycerin, mannitol, sorbitol and maltitol) and inorganic binders (such as silica gel, aluminum silica gel, bee gum, -- and Laponite). For example, the gel carrier may contain a polymer in combination with a synthetic binder and/or a natural polyol, such as 12-18% synthetic binder (e.g., propylene glycol), 40-50% natural polyol (e.g., glycerin), and 0.5-4% of polymer (e.g., Carbopol).
In some embodiments, the composition comprises flavoring agents. Flavoring agents that are useful include essential oils as well as various flavoring aldehydes, esters, alcohols, and similar materials. Examples of the essential oils include oils of spearmint, peppermint, wintergreen, sassafras, clove, sage, eucalyptus, marjoram, cinnamon, lemon, lime, grapefruit, and orange. Also useful are such chemicals as menthol, carvone, and anethole, and synthetic flavors like Evercool, and derivatives of cyclic alpha-keto enamines. Of these, the most commonly employed are the oils of peppermint, spearmint and wintergreen. The flavoring agent is incorporated in the brightening liquid composition of the present disclosure at a concentration of about 0.05 to about 2%, or preferably about 0.1 to about 0.5%
by weight of the composition. A sweetening material may also be employed as a complement to the flavoring material. Suitable sweetening agents are water soluble and include sodium saccharin, sodium cyclamate, xylitol, perillartien, D-tryptophan, aspartame, dihydrochalcones and the like.
In some embodiments, the composition comprises a brightening particulate. The brightening particulates may comprise a form of calcium phosphate. The calcium phosphate may have a structure selected from tetracalcium phosphate, amorphous calcium phosphate, alpha-tricalcium phosphate, beta-tricalcium phosphate and hydroxyapatite (Ca5 (OH)(PO4)3). The calcium phosphate may be a substantially aqueous insoluble calcium phosphate and non-crystalline, poorly crystalline or crystalline form such as, for example, crystalline hydroxyapatite. Preferably, the composition includes nanoparticles of hydroxyapatite.
Hydroxyapatite has a similar physical structure as tooth enamel, and thus has a strong affinity to the tooth enamel surfaces, resulting in the hydroxyapatite particulates imparting a "natural" white appearance to the enamel surface. The hydroxylapatite crystals may also cause accumulation of an electrostatic charge, due to the pressure and friction exerted by the sponge, facilitating and amplifying the penetration of ions in the enamel structure. A large amount of the nanoparticles of hydroxyapatite could even percolate in the enamel and facilitate a deposition of calcium and calcium phosphate ions on the enamel.
The hydroxyapatite may also decrease the deleterious effects of peroxides and allow remineralization of the enamel. Preferably, hydroxyapatite is present in the composition of the present disclosure at a concentration of about 0.5-5%, or about 1-2% by weight of the composition. In some embodiments, hydroxyapatite particles can comprise aggregates of individual hydroxyapatite particles. For example, such aggregates can have a mean diameter of from about 100 nm to about 1000 nm, and comprise hydroxyapatite particles having a mean diameter of about 10 nm to about 200 nm.
In some embodiments, the composition further comprises one or more of fluoride, triclosan, detergent, clorhexidine, cetylpyridinium, stannous fluoride, and an amine fluoride. Examples of amine fluorides include olaflur (N'-octadecyltrimethylenediamine-N,N,N'-tris(2-ethanol)-dihydrofluoride) and dectaflur (9-octadecenylamine-hydrofluoride). Exemplary detergents include delmopinol, sodium lauryl sulfate (SLS), and cocoamidopropyl betaine (CAPB).
In certain embodiments, the composition further comprises an antimicrobial agent. For example, the antimicrobial agent may be selected from an antiviral agent or an antibiotic agent. Antibiotics include, for example, vancomycin, penicillin, amoxicillin, ampicillin, cefotaxime, ceftriaxone, cefixime, rifampinmetronidazole, doxycycline, tetracycline, minocycline, azithromycin, tacrolimus, cyclosporine, sirolimus, everolimus, ascomycin, erythromycin, clarithromycin, clindamycin, lincomycin, dirithromycin, josamycin, spiramycin, diacetyl-midecamycin, tylosin, roxithromycin, ABT-773, telithromycin, leucomycins, lincosamide, dactinomycin, daunorubicin, doxorubicin, idarubicin, anthracyclines, mitoxantrone, bleomycins, plicamycin, mitomycin and streptomycin.
In some embodiments, the composition comprises a stabilizing agent. The stabilizing agent utilized in the aqueous gel is present in an amount ranging from about 0.01%
to about 5% by weight of the aqueous gel. An amount of approximately 1% stabilizing agent is preferred.
The stabilizing agent is typically selected from aminocarboxylic acids and salts thereof.
Preferred stabilizers are selected from aminocarboxylic acids and alkali and/or alkali earth metal salts thereof. Suitable aminocarboxylic acids include trans-1,2-cyclohexylene dinitrilotetraacetic acid (CDTA), ethylenediamine tetraacetic acid (EDTA), N-(2-hydroxyethyl) ethylenediamine triacetic acid (HEDTA), Nitrilotriacetic acid (NTA), diethylene triamine pentaacetic acid (DTPA), triethylene tetraamine hexaacetic acid (TTHA), and ethyleneglycol bis (2-aminoethylether) tetraacetic acid (GEDTA).
In addition to the aforementioned components, a neutralizing agent may be added to the composition. The inorganic and organic neutralizing agents which may be employed are bases. Suitable bases include alkali metal hydroxides and ammonium hydroxide, carbonates, alkoxides, oxides, peroxides, superoxides, and water soluble organic amines.
Amino acids such as 13-alanine and lysine can also be used for neutralization and viscosity modification.
Preferred bases include sodium hydroxide, potassium hydroxide, ammonium hydroxide, triethanolamine (TEA), aminomethyl propanol (AMP), 2-amino-2-hydroxymethy1-1,3 -propanediol (Tromethamine), tetrahydroxypropyl ethylenediamine, and tris(hydroxymethypaminomethane (TRIS). In certain embodiments, the neutralizing agent will be used to obtain a brightening composition having a pH of about 4 to 10, or about 5 to 7, or about 5.5 to 6.5.
The following are non-limiting examples of aspects and embodiments of the present disclosure.
An exemplary composition was prepared by mixing the following components.
Components % content Propylene Glycol,-,.. 16%
Purified Water m-, 18%
Glycerin A--- 45%
Carbamide Peroxide ....-. 15%
Disodium EDTA,=-= 1%
CARBOPOL 940..- 2%
Sodium Hydroxide =-=. 0.5%
Nano-crystals Hydroxylapatite . 1.5%
Sodium Saccharine ---, 0.1%
Mint Flavoring ----, 0.2%
Evaluation of the antibacterial activity of the composition using a disc diffusion assay.
Nutrient medium was inoculated with fresh bacteria from the gum-teeth junction and cultured at 37 C with agitation. 24h later 500 4, of bacterial suspension were spread onto agar petri dishes, and sterile nylon discs of 8mm were placed on the plates.
15 vt.L of test solutions (saline, 1% H202 and 4.3% H202) or 5004 of the composition of Example 1 were applied on the disc, and the plates were incubated at 37 C for 24h. As shown in Figures 3 and 4, the composition of Example 1 displays a clear bactericidal activity on bacteria from gum-teeth junction as illustrated by the diameter of bacteria-free zone around the disc.
It should be appreciated that the disclosure is not limited to the particular embodiments described and illustrated herein but includes all modifications and variations falling within the scope of the disclosure as defined in the appended claims.
Claims (83)
1. A method for preventing or treating periodontal disease, comprising:
providing an antimicrobial composition disposed within a reservoir, the reservoir being fluidly connected to an exterior surface of an applicator having a frictional stress value sufficient to cause mechanical displacement of a biofilm present on an oral cavity surface;
dispensing said antimicrobial composition through said applicator onto said exterior surface of said applicator;
applying the antimicrobial composition to the oral cavity surface; and rubbing said applicator onto said oral cavity surface and exerting pressure towards said oral cavity surface.
providing an antimicrobial composition disposed within a reservoir, the reservoir being fluidly connected to an exterior surface of an applicator having a frictional stress value sufficient to cause mechanical displacement of a biofilm present on an oral cavity surface;
dispensing said antimicrobial composition through said applicator onto said exterior surface of said applicator;
applying the antimicrobial composition to the oral cavity surface; and rubbing said applicator onto said oral cavity surface and exerting pressure towards said oral cavity surface.
2. The method of claim 1, wherein rubbing said applicator onto said oral cavity surface and exerting pressure towards said oral cavity surface occurs at the same time as applying the antimicrobial composition to the oral cavity surface.
3. The method of claim 1, wherein rubbing said applicator onto said oral cavity surface and exerting pressure towards said oral cavity surface occurs before applying the antimicrobial composition to the oral cavity surface.
4. The method of claim 1, wherein rubbing said applicator onto said oral cavity surface and exerting pressure towards said oral cavity surface occurs after applying the antimicrobial composition to the oral cavity surface.
5. The method of any of claims 1 to 4, further comprising a step of applying new antimicrobial composition to the oral cavity surface following rubbing said applicator onto said oral cavity surface and exerting pressure towards said oral cavity surface.
6. The method of any of claims 1 to 5, wherein the oral cavity surface is a gum surface, a tooth surface, or both gum and tooth surfaces.
7. The method of claim 6, wherein the gum or tooth surfaces include periodontal pockets, said method further comprising pushing the antimicrobial composition into the periodontal pockets.
8. The method of any of claims 1 to 7, wherein said antimicrobial composition comprises a peroxide source.
9. The method of claim 8, wherein the peroxide source is urea peroxide.
10. The method of any of claims 1 to 9, wherein said antimicrobial composition includes hydroxyapatite.
11. The method of claim 10, wherein the hydroxyapatite has a particle size ranging from 10-200 nm.
12. The method of any of claims 1 to 11, wherein said antimicrobial composition comprises an antimicrobial agent.
13. The method of claim 12, wherein the antimicrobial agent is an antibiotic agent.
14. The method of claim 13, wherein the antibiotic agent is selected from tetracycline, doxycycline, minocycline, amoxicillin and azithromycin.
15. The method of claim 12, wherein the antimicrobial agent is an antiviral agent.
16. The method of any of claims 1 to 15, wherein the antimicrobial composition comprises one or more of: fluoride, triclosan, sodium bicarbonate, sweetening agent, detergent, chlorhexidine, cetylpyridinium, stannous fluoride and an amine fluoride.
17. The method of any of claims 1 to 16, wherein the composition is applied to the oral cavity surface at least once daily.
18. The method of any of claims 1 to 16, wherein the composition is applied to the oral cavity surface at least once weekly.
19. The method of any of claims 1 to 18, wherein a contact area between the exterior surface of the applicator and the oral cavity surface is about 0.25-400 mm2, about 4-100 mm2 or about 9-25 mm2.
20. The method of any of claims 1 to 19, wherein the applicator has a frictional stress value greater than about 0.001 N/mm2.
21. The method of any of claims 1 to 20, wherein the applicator comprises pores having a diameter of 0.1-1000 µm.
22. The method of any of claims 1 to 21, wherein the exterior surface of the applicator comprises bristles.
23. A method for preventing or treating periodontal disease, comprising:
mechanically displacing a biofilm on an oral cavity surface; and applying an antimicrobial composition to the oral cavity surface.
mechanically displacing a biofilm on an oral cavity surface; and applying an antimicrobial composition to the oral cavity surface.
24. The method of claim 23, wherein applying the antimicrobial composition comprises contacting the oral cavity surface with an exterior surface of an applicator fluidly connected to a reservoir containing the antimicrobial composition.
25. The method of claim 24, wherein mechanically displacing the biofilm comprises rubbing said oral cavity surface and exerting pressure towards said oral cavity surface with the external surface of the applicator, the external surface of the applicator having a frictional stress value sufficient to cause mechanical displacement of the biofilm on the oral cavity surface.
26. The method of any of claims 23 to 25, wherein the antimicrobial composition is applied to the oral cavity surface at the same time as mechanically displacing the biofilm on the oral cavity surface.
27. The method of any of claims 23 to 25, wherein the antimicrobial composition is applied to the oral cavity surface before mechanically displacing the biofilm on the oral cavity surface.
28. The method of any of claims 23 to 25, wherein the antimicrobial composition is applied to the oral cavity surface after mechanically displacing the biofilm on the oral cavity surface.
29. The method of any of claims 23 to 25, wherein applying said antimicrobial composition to the oral cavity surface comprises supplying a flow of said antimicrobial composition from a reservoir to an applicator which is rubbed on the oral cavity surface.
30. The method of any of claims 23 to 29, wherein the oral cavity surface is a gum surface, a tooth surface, or both gum and tooth surfaces.
31. The method of claim 30, wherein the gum or tooth surfaces includes periodontal pockets, said method further comprising pushing the antimicrobial composition into the periodontal pockets.
32. The method of any of claims 23 to 30, wherein said antimicrobial composition comprises a peroxide source.
33. The method of claim 32, wherein the peroxide source is urea peroxide.
34. The method of any of claims 23 to 33, wherein said antimicrobial composition includes hydroxyapatite.
35. The method of claim 34, wherein the hydroxyapatite has a particle size ranging from 10-200 nm.
36. The method of any of claims 23 to 35, wherein said antimicrobial composition comprises an antimicrobial agent.
37. The method of claim 36, wherein the antimicrobial agent is an antibiotic agent.
38. The method of claim 37, wherein the antibiotic agent is selected from tetracycline, doxycycline, minocycline, amoxicillin and azithromycin.
39. The method of claim 36, wherein the antimicrobial agent is an antiviral agent.
40. The method of any of claims 23 to 39, wherein the antimicrobial composition comprises one or more of: fluoride, triclosan, sodium bicarbonate, sweetening agent, detergent, chlorhexidine, cetylpyridinium, stannous fluoride and an amine fluoride.
41. The method of any of claims 23 to 40, wherein the antimicrobial composition is applied to the oral cavity surface and the biofilm displaced at least once daily.
42. The method of any of claims 23 to 40, wherein the antimicrobial composition is applied to the oral cavity surface and the biofilm displaced at least once weekly.
43. The method of any of claims 24 to 42, wherein the applicator comprises pores having a diameter of 0.1-1000 µm.
44. The method of any of claims 24 to 43, wherein the exterior surface of the applicator comprises bristles.
45. The method of any of claims 24 to 44, wherein a contact area between the exterior surface of the applicator and the oral cavity surface is about 0.25-400 mm2, about 4-100 mm2 or about 9-25 mm2.
46. The method of any of claims 24 to 45, wherein the exterior surface of the applicator has a frictional stress value greater than about 0.001 N/mm2.
47. Use of an antimicrobial composition for preventing or treating periodontal disease, wherein the antimicrobial composition is disposed within a reservoir fluidly connected to an exterior surface of an applicator for dispensing the antimicrobial composition through the applicator onto the exterior surface of the applicator for applying the antimicrobial composition to the oral cavity surface, said exterior surface of the applicator having a frictional stress value sufficient to cause mechanical displacement of the biofilm when the applicator exterior surface is rubbed against the oral cavity surface and pressure is exerted towards said oral cavity surface.
48. The use of claim 47, wherein the applicator and reservoir are arranged to deliver the antimicrobial composition onto the exterior surface of the applicator at the same time as rubbing said applicator exterior surface onto said oral cavity surface and exerting pressure towards said oral cavity surface, to prevent or treat periodontal disease.
49. The use of claim 47, wherein the applicator and reservoir are arranged to deliver the antimicrobial composition onto the exterior surface of the applicator before said applicator exterior surface is rubbed onto said oral cavity surface and exerting pressure towards said oral cavity surface, to prevent or treat periodontal disease.
50. The use of claim 47, wherein the applicator and reservoir are arranged to deliver the antimicrobial composition onto the exterior surface of the applicator after rubbing said applicator exterior surface onto said oral cavity surface and exerting pressure towards said oral cavity surface, to prevent or treat periodontal disease.
51. The use of any of claims 47 to 50, wherein the oral cavity surface is a gum surface, a tooth surface, or both gum and tooth surfaces.
52. The use of any of claims 47 to 51, wherein said antimicrobial composition comprises a peroxide source.
53. The use of claim 52, wherein the peroxide source is urea peroxide.
54. The use of any of claims 47 to 53, wherein said antimicrobial composition includes hydroxyapatite.
55. The use of claim 54, wherein the hydroxyapatite has a particle size ranging from 10-200 nm.
56. The use of any of claims 47 to 55, wherein said antimicrobial composition comprises an antimicrobial agent.
57. The use of claim 56, wherein the antimicrobial agent is an antibiotic agent.
58. The use of claim 57, wherein the antibiotic agent is selected from tetracycline, doxycycline, minocycline, amoxicillin and azithromycin.
59. The use of claim 56, wherein the antimicrobial agent is an antiviral agent.
60. The use of any of claims 47 to 59, wherein the antimicrobial composition comprises one or more of: fluoride, triclosan, sodium bicarbonate, sweetening agent, detergent, chlorhexidine, cetylpyridinium, stannous fluoride and an amine fluoride.
61. The use of any of claims 47 to 60, wherein a contact area between the exterior surface of the applicator and the oral cavity surface is about 0.25-400 mm2, about 4-100 mm2 or about 9-25 mm2.
62. The use of any of claims 47 to 61, wherein the applicator has a frictional stress value greater than about 0.001 N/mm2.
63. The use of any of claims 47 to 62, wherein the applicator comprises pores having a diameter of 0.1-1000 µm.
64. The use of any of claims 47 to 63, wherein the applicator comprises bristles.
65. Use of an antimicrobial composition on an oral cavity surface with mechanical displacement of a biofilm on the oral cavity surface, for preventing or treating periodontal disease.
66. The use of claim 65, wherein the antimicrobial composition is disposed within a reservoir fluidly connected to an exterior surface of an applicator for contacting the oral cavity surface to apply the antimicrobial composition to the oral cavity surface, said applicator having a frictional stress value sufficient to cause mechanical displacement of the biofilm present on the oral surface cavity.
67. The use of claim 66, wherein the applicator and reservoir are arranged to deliver the antimicrobial composition onto the exterior surface of the applicator at the same time as displacing the biofilm, to prevent or treat periodontal disease.
68. The use of claim 66, wherein the applicator and reservoir are arranged to deliver the antimicrobial composition onto the exterior surface of the applicator before displacing the biofilm, to prevent or treat periodontal disease.
69. The use of claim 66, wherein the applicator and reservoir are arranged to deliver the antimicrobial composition onto the exterior surface of the applicator after displacing the biofilm, to prevent or treat periodontal disease.
70. The use of any of claims 65 to 69, wherein the oral cavity surface is a gum surface, a tooth surface, or both gum and tooth surfaces.
71. The use of any of claims 65 to 70, wherein said antimicrobial composition comprises a peroxide source.
72. The use of claim 71, wherein the peroxide source is urea peroxide.
73. The use of any of claims 65 to 72, wherein said antimicrobial composition includes hydroxyapatite.
74. The use of claim 73, wherein the hydroxyapatite has a particle size ranging from 10-200 nm.
75. The use of any of claims 65 to 74, wherein said antimicrobial composition comprises an antimicrobial agent.
76. The use of claim 75, wherein the antimicrobial agent is an antibiotic agent.
77. The use of claim 76, wherein the antibiotic agent is selected from tetracycline, doxycycline, minocycline, amoxicillin and azithromycin.
78. The use of claim 75, wherein the antimicrobial agent is an antiviral agent.
79. The use of any of claims 65 to 78, wherein the antimicrobial composition comprises one or more of: fluoride, triclosan, sodium bicarbonate, sweetening agent, detergent, chlorhexidine, cetylpyridinium, stannous fluoride and an amine fluoride.
80. The use of any of claims 66 to 79, wherein a contact area between the exterior surface of the applicator and the oral cavity surface is about 0.25-400 mm2, about 4-100 mm2 or about 9-25 mm2.
81. The use of any of claims 66 to 80, wherein the applicator has a frictional stress value greater than about 0.001 N/mm2.
82. The use of any of claims 66 to 81, wherein the applicator comprises pores having a diameter of 0.1-1000 µm.
83. The use of any of claims 66 to 82, wherein the applicator comprises bristles.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/437,553 US20120251981A1 (en) | 2011-03-22 | 2012-04-02 | Device and method for administering teeth whitening and antimicrobial compositions |
| US13/437,553 | 2012-04-02 | ||
| PCT/CA2013/000314 WO2013149322A1 (en) | 2012-04-02 | 2013-04-02 | Preventing or treating periodontal disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2867507A1 true CA2867507A1 (en) | 2013-10-10 |
Family
ID=49299882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2867507A Abandoned CA2867507A1 (en) | 2012-04-02 | 2013-04-02 | Preventing or treating periodontal disease |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP2833895A4 (en) |
| JP (1) | JP2015512423A (en) |
| KR (1) | KR20140140062A (en) |
| CN (1) | CN104271143A (en) |
| AU (1) | AU2013243174B2 (en) |
| CA (1) | CA2867507A1 (en) |
| HK (1) | HK1205464A1 (en) |
| IL (1) | IL234867A0 (en) |
| IN (1) | IN2014DN08827A (en) |
| MX (1) | MX2014011924A (en) |
| RU (1) | RU2014144299A (en) |
| SG (1) | SG11201405849YA (en) |
| WO (1) | WO2013149322A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11992640B2 (en) | 2016-11-28 | 2024-05-28 | The Jenex Corporation | Devices for applying a topical treatment |
| US11344707B2 (en) | 2016-11-28 | 2022-05-31 | Therma Bright Inc. | Devices for applying a topical treatment |
| JP7208613B2 (en) * | 2018-08-29 | 2023-01-19 | リジェンティス株式会社 | Devices and kits for bleaching teeth |
| JP2023503060A (en) * | 2019-11-27 | 2023-01-26 | ザ プロクター アンド ギャンブル カンパニー | medication indicator |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5611687A (en) * | 1995-11-06 | 1997-03-18 | Dental Concepts Inc. | Oral hygiene delivery system |
| CN2250124Y (en) * | 1995-11-24 | 1997-03-26 | 杨上闰 | Pen for cleaning tooth stain |
| US5829976A (en) * | 1996-04-12 | 1998-11-03 | Green; Warren F. | Medicament-containing interproximal dental brush |
| JPH115722A (en) * | 1997-06-13 | 1999-01-12 | Hideki Aoki | Aqueous composition for washing oral cavity |
| JP4199333B2 (en) * | 1998-08-07 | 2008-12-17 | 宇部マテリアルズ株式会社 | Dentifrice composition |
| EP1653909A4 (en) * | 2003-07-28 | 2009-04-08 | Britesmile Professional Inc | Compositions, methods, devices, and kits for maintaining or enhancing tooth whitening |
| JP3836456B2 (en) * | 2003-08-08 | 2006-10-25 | 株式会社ジーシー | 1 paste tooth bleaching material |
| EP1686919A1 (en) * | 2003-10-14 | 2006-08-09 | Colgate-Palmolive Company | An applicator and method for applying a tooth whitening composition |
| US20060142411A1 (en) * | 2004-12-29 | 2006-06-29 | Sayed Ibrahim | Instant tooth whitening with silicone resin and silicone adhesive |
| US20060280700A1 (en) * | 2005-06-08 | 2006-12-14 | Isler Stuart L | Oral hygiene system to fight the effects of aging on the mouth, gums, and teeth |
| FR2909844B1 (en) * | 2006-12-14 | 2009-09-11 | Oreal | POINTE FELT PEN FOR NAIL MAKE-UP |
| WO2009132223A1 (en) * | 2008-04-23 | 2009-10-29 | Unicep Packaging, Inc. | Dispensing and applicator devices |
-
2013
- 2013-04-02 WO PCT/CA2013/000314 patent/WO2013149322A1/en not_active Ceased
- 2013-04-02 CN CN201380018455.XA patent/CN104271143A/en active Pending
- 2013-04-02 SG SG11201405849YA patent/SG11201405849YA/en unknown
- 2013-04-02 KR KR1020147027731A patent/KR20140140062A/en not_active Withdrawn
- 2013-04-02 RU RU2014144299A patent/RU2014144299A/en unknown
- 2013-04-02 AU AU2013243174A patent/AU2013243174B2/en not_active Expired - Fee Related
- 2013-04-02 JP JP2015503717A patent/JP2015512423A/en active Pending
- 2013-04-02 EP EP13772214.6A patent/EP2833895A4/en not_active Withdrawn
- 2013-04-02 CA CA2867507A patent/CA2867507A1/en not_active Abandoned
- 2013-04-02 IN IN8827DEN2014 patent/IN2014DN08827A/en unknown
- 2013-04-02 HK HK15106091.8A patent/HK1205464A1/en unknown
- 2013-04-02 MX MX2014011924A patent/MX2014011924A/en unknown
-
2014
- 2014-09-29 IL IL234867A patent/IL234867A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013149322A1 (en) | 2013-10-10 |
| IL234867A0 (en) | 2014-12-31 |
| AU2013243174A1 (en) | 2014-10-09 |
| CN104271143A (en) | 2015-01-07 |
| EP2833895A1 (en) | 2015-02-11 |
| HK1205464A1 (en) | 2015-12-18 |
| SG11201405849YA (en) | 2014-10-30 |
| EP2833895A4 (en) | 2016-03-02 |
| IN2014DN08827A (en) | 2015-05-22 |
| MX2014011924A (en) | 2015-05-11 |
| JP2015512423A (en) | 2015-04-27 |
| RU2014144299A (en) | 2016-05-27 |
| KR20140140062A (en) | 2014-12-08 |
| AU2013243174B2 (en) | 2018-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20120251981A1 (en) | Device and method for administering teeth whitening and antimicrobial compositions | |
| US20120244491A1 (en) | Device and method for teeth brightening | |
| TWI514966B (en) | Biofilm disruptive compositions | |
| Slots | Low‐cost periodontal therapy | |
| US8815216B2 (en) | Applicator and method for applying a tooth whitening composition | |
| TW201615199A (en) | Oral compositions containing polyguanidinium compounds and methods of manufacture and use thereof | |
| US20130137063A1 (en) | Delivery of Oral Care Products | |
| CA2867507A1 (en) | Preventing or treating periodontal disease | |
| CN113164339B (en) | Tooth care and tooth cleaning composition, system and tooth cleaning method | |
| WO2014151244A1 (en) | Compositions and methods for remineralizing tooth enamel using calcium phosphate nanoparticles | |
| Ahmad et al. | Dental therapeutic systems | |
| RU2376917C1 (en) | Oral care tool comprising facility for oral care | |
| CN109219418A (en) | The application of oral cavity nursing agent | |
| US20150050620A1 (en) | Preventing or treating periodontal disease | |
| US20180325640A1 (en) | Method and system for the administration of oral care particles | |
| JP2015512423A5 (en) | ||
| US20240099451A1 (en) | Dental composition and related device and method | |
| US20030095930A1 (en) | Composition for oral hygiene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20190403 |